Evidence map›Paper›PMID 27647925›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Cell cycle progression in Caulobacter requires a nucleoid-associated protein with high AT sequence recognition.

Dante P Ricci, Michael D Melfi, Keren Lasker, David L Dill, Harley H McAdams, Lucy Shapiro

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. TheJournal of bacteriology · 2023
    Article
  10. ThebioRxiv : the preprint server for biology · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Dante P RicciDepartment of Developmental Biology, Stanford University, Stanford, CA 94305.
Michael D MelfiDepartment of Developmental Biology, Stanford University, Stanford, CA 94305; Department of Chemistry, Stanford University, Stanford, CA 94305.
Keren LaskerDepartment of Developmental Biology, Stanford University, Stanford, CA 94305.
David L DillDepartment of Computer Science, Stanford University, Stanford, CA 94305.
Harley H McAdamsDepartment of Developmental Biology, Stanford University, Stanford, CA 94305.
Lucy ShapiroDepartment of Developmental Biology, Stanford University, Stanford, CA 94305; shapiro@stanford.edu.
Stanford University · US

Funding

REGULATION OF DIFFERENTIATION IN CAULOBACTERR01GM032506 · NIGMS · YESHIVA UNIVERSITY · PI SHAPIRO, LUCILLE · 1985 to 2014
$7.1M
Integration of regulatory networks and subcellular architecture to control the Caulobacter cell cycleR35GM118071 · NIGMS · STANFORD UNIVERSITY · PI SHAPIRO, LUCILLE · 2016 to 2020
$3.2M
REGULATION OF DIFFERENTIATION IN CAULOBACTERR37GM032506 · NIGMS · STANFORD UNIVERSITY · PI SHAPIRO, LUCILLE · 1993 to 2002
$1.4M
A systems analysis of novel essential cell cycle components in CaulobacterF32GM109650 · NIGMS · STANFORD UNIVERSITY · PI RICCI, DANTE · 2014 to 2015
$102k
NIGMS NIH HHS F32 GM109650NIGMS NIH HHS R01 GM032506NIGMS NIH HHS R35 GM118071NIGMS NIH HHS R37 GM032506
6 · The paper itself

Abstract

Faithful cell cycle progression in the dimorphic bacterium Caulobacter crescentus requires spatiotemporal regulation of gene expression and cell pole differentiation. We discovered an essential DNA-associated protein, GapR, that is required for Caulobacter growth and asymmetric division. GapR interacts with adenine and thymine (AT)-rich chromosomal loci, associates with the promoter regions of cell cycle-regulated genes, and shares hundreds of recognition sites in common with known master regulators of cell cycle-dependent gene expression. GapR target loci are especially enriched in binding sites for the transcription factors GcrA and CtrA and overlap with nearly all of the binding sites for MucR1, a regulator that controls the establishment of swarmer cell fate. Despite constitutive synthesis, GapR accumulates preferentially in the swarmer compartment of the predivisional cell. Homologs of GapR, which are ubiquitous among the α-proteobacteria and are encoded on multiple bacteriophage genomes, also accumulate in the predivisional cell swarmer compartment when expressed in Caulobacter The Escherichia coli nucleoid-associated protein H-NS, like GapR, selectively associates with AT-rich DNA, yet it does not localize preferentially to the swarmer compartment when expressed exogenously in Caulobacter, suggesting that recognition of AT-rich DNA is not sufficient for the asymmetric accumulation of GapR. Further, GapR does not silence the expression of H-NS target genes when expressed in E. coli, suggesting that GapR and H-NS have distinct functions. We propose that Caulobacter has co-opted a nucleoid-associated protein with high AT recognition to serve as a mediator of cell cycle progression.

Indexed as

Cell CycleAlphaproteobacteriaAmino Acid SequenceAT Rich SequenceBacterial ProteinsBase SequenceCaulobacter crescentusCell DivisionChromosomes, BacterialDNA, BacterialDNA-Binding ProteinsEscherichia coliEscherichia coli ProteinsGene Expression Regulation, BacterialGenes, BacterialGenetic LociBacterial ProteinsDNA, BacterialDNA-Binding ProteinsEscherichia coli ProteinsRNA, MessengerasymmetryAT-richCaulobactercell cyclenucleoid-associated protein

Identifiers

PMID27647925
PMCPMC5056096
OpenAlexW2521149056

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.